Good news for patients with untreatable end-stage age-related macular degeneration. Developer of advanced visual prosthetic devices for individuals with age-related macular degeneration, VisionCare Ophthalmic Technologies, Inc., announced today about the FDA approval of their Implantable telescope for End-Stage AMD.
The investigational Implantable Miniature Telescope by Dr. Isaac Lipshitz) is designed to be a solution for moderate to profound vision loss due to advanced, end-stage forms of AMD that have no current surgical or medical treatment options.
The pie size device renders enlarged central vision images over a wide area of the retina to improve central vision, while the non-operated eye provides peripheral vision for mobility and orientation.
FDA Ophthalmic Devices Advisory Panel unanimously recommended that the FDA approve, with conditions, the premarket application for its implantable telescope for End-Stage AMD.
The implantable telescope is the first medical device to be recommended by the panel for FDA approval for End-Stage AMD, which is a leading cause of untreatable blindness in the U.S. End-Stage AMD occurs when the macula in each eye is irreversibly degenerated and no longer provides detailed central vision required for common everyday activities such as recognizing people and facial expressions, or watching television.
Filed under Eye Care Products, Macular Degeneration | Tags: Common, end-stage age-related macular degeneration, eye, FDA, Forms, Implantable Miniature Telescope, Implantable telescope, Implantable telescope for End-Stage AMD | 1 Comment